Search Results for "Prasugrel Clopidogrel Cross Allergy"
Original Source: Allergic Reactions to Clopidogrel and Cross-Reactivity to Other Agents.
Clopidogrel is a widely used antiplatelet agent, particularly after coronary stent implantation. About 1% of patients have allergic or hematologic adverse reactions to clopidogrel. This has important therapeutic implications, as premature discontinuation of clopidogrel is the strongest risk factor for stent thrombosis. Clopidogrel allergy most commonly manifests as a rash. It is important to distinguish this from other causes of rash occurring in patients who have had a recent coronary stent. Although antih...
Matching Channels
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms an...
The increasing prevalence of allergy is a major health issue. Often manifested as atopic dermatitis in early childhood, allergies can progress to allergic rhinoconjunctivitis and severe allergic ast...
O2PR is a specialist PR and communications consultancy providing bespoke services to public and private sector organisations operating in the fields of science, engineering and technology. The de...
Matching News
Prasugrel, Clopidogrel Look Similar In ACS Patients
Study outcomes suggest some efficacy advantages for the more expensive prasugrel, but that drug was unable to top clopidogrel in the primary efficacy endpoint.
Prasugrel does as well as clopidogrel in PCI
NEW YORK (Reuters Health) - Prasugrel is as safe and effective as clopidogrel, when given after bivalirudin to patients with acute coronary syndrome (ACS) undergoing percutaneous coronary interven...
Ticagrelor, prasugrel overcome high on-clopidogrel platelet reactivity
NEW YORK (Reuters Health) - Both ticagrelor and prasugrel significantly improved platelet inhibition when clopidogrel wasn't effective in patients having percutaneous coronary interventions (PCI).
Prasugrel versus clopidogrel for ACS patients managed without revascularisation
The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel a...
ContextThe relationship of platelet function testing measurements with outcomes in patients with acute coronary syndromes (ACS) initially managed medically without revascularization is unknown.Objecti...
Low-dose prasugrel reduces high on-clopidogrel platelet reactivity in elderly
NEW YORK (Reuters Health) - In older patients with acute coronary syndrome (ACS) and high on-clopidogrel platelet reactivity, reduced-dose prasugrel (5 mg/d) was significantly more effective than...
Prasugrel after clopidogrel safe in acute coronary syndrome: study
NEW YORK (Reuters Health) - Prasugrel reloading after clopidogrel loading appears safe before percutaneous interventions for acute coronary syndrome (ACS), a new paper says.
Prasugrel Bests Clopidogrel in TRILOGY-ACS Angiography Cohort
ACS patients randomized to prasugrel following coronary angiography had significantly lower rates of major cardiovascular events compared with patients treated with clopidogrel. The findings run count...
Matching PubMed Articles
Allergic Reactions to Clopidogrel and Cross-Reactivity to Other Agents.
Clopidogrel is a widely used antiplatelet agent, particularly after coronary stent implantation. About 1% of patients have allergic or hematologic adverse reactions to clopidogrel. This has important...
The interaction between proton pump inhibitors (PPIs) and clopidogrel/prasugrel were investigated. The IC(50) values of omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on the met...
This study sought to investigate the efficacy, safety, and antiplatelet effect of prasugrel as compared with clopidogrel in patients with high on-treatment platelet reactivity (HTPR) after elective pe...
A comparison of the metabolism of clopidogrel and prasugrel.
Importance of the field: The administration of dual antiplatelet therapy with aspirin and a thienopyridine for the prevention of thrombosis in patients with acute coronary syndrome undergoing percutan...
The goal of this study was to assess the offset of the antiplatelet effects of prasugrel and clopidogrel.
